Follow Us
https://www.thebody.com/category/hiv-drugs-development/tag/news

The Latest

Screenshot from Carl Dieffenbach and Anne Rancourt Final IAS 2019 Video

Updates on HIV Treatment Advances and Other Notes From IAS 2019

NIAID's Carl Dieffenbach, Ph.D., joins Anne Rancourt to discuss some key takeaways from the 10th International AIDS Society Conference on HIV Science.

PrEP Trials: The Benefits -- and Challenges -- of Seeking Community Input Img

PrEP Trials: The Benefits -- and Challenges -- of Seeking Community Input

Last fall, community activists voiced concerns over the roll out of studies on Descovy (TAF/FTC) as pre-exposure prophylaxis (PrEP) without adequately involving community advisors.

Joseph Eron, Jr., M.D., presents 96-week study data from LATTE-2, at IAS 2017 (Credit: Warren Tong)

Long-Acting Injectable HIV Treatment Moves Closer to Reality

Long-acting injectable treatment takes another step closer to being a real-world option for people living with HIV, with new study results presented at IAS 2017.

Surprise FDA Approval of Generic Truvada Is a 'Wakeup Call' for Activists Img

Surprise FDA Approval of Generic Truvada Is a 'Wakeup Call' for Activists

The surprise approval of generic Truvada (tenofovir disoproxil fumarate and emtricitabine) by the U.S. Food and Drug Administration (FDA) on June 9 left patients, advocates and doctors scrambling to understand exactly when the generic will become ava...

Ibalizumab: First Long-Acting HIV Treatment Available Now Via Expanded Access Img

Ibalizumab: First Long-Acting HIV Treatment Available Now Via Expanded Access

Ibalizumab, a drug that works against multi-drug-resistant HIV, is now available via the manufacturer's expanded access program.

Real or Not? HIV Cure in Animals Using CRISPR Gene Editing Img

Real or Not? HIV Cure in Animals Using CRISPR Gene Editing

You may have heard about the "HIV cure with gene editing in animals" story. Here's some help making sense of the story, including what's true or not, and what to get excited about.

Back to the Future: A New HIV Medication Offers Hope to Those Who've Exhausted Their Options Img

Back to the Future: A New HIV Medication Offers Hope to Those Who've Exhausted Their Options

In a way, the story of ibalizumab is a time travel tale back to 1994, before any protease inhibitor drugs were approved.

People With Multidrug-Resistant HIV Can Now Start Treatment on the Experimental Drug Ibalizumab Img

People With Multidrug-Resistant HIV Can Now Start Treatment on the Experimental Drug Ibalizumab

For the small percentage of HIV patients struggling with drug resistance, an expanded access program for a new injectable treatment might be the answer.

HIV Activists Seek to Accelerate Development of Immune Enhancing Therapies for Immunologic Non-Responders Img

HIV Activists Seek to Accelerate Development of Immune Enhancing Therapies for Immunologic Non-Responders

A coalition of HIV/AIDS activists are calling for renewed attention to HIV-positive people termed immunologic non-responders.

protesters

Why Are HIV Groups Charging Gilead With Bad Behavior in New PrEP Trial?

"Gilead is not following the accepted standard for community engagement in its new pre-exposure prophylaxis (PrEP) trial," write Anna Forbes and Marc-André LeBlanc, explaining that concern is inspired, in part, by controversies in earlier PrEP trials...